4//SEC Filing
LAPOINTE ANTHONY GREGG 4
Accession 0001140361-23-034286
CIK 0001034842other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 6:45 PM ET
Size
12.8 KB
Accession
0001140361-23-034286
Insider Transaction Report
Form 4
Lapointe Gregg Anthony
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-26+30,000→ 30,000 totalExercise: $1.32Exp: 2033-05-26→ Common Stock (30,000 underlying) - Award
Common Stock
2023-05-26+25,000→ 75,000 total
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
- [F2]The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001331860
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 6:45 PM ET
- Size
- 12.8 KB